A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

BACKGROUND: Bone metastases represent an important source of morbidity in cancer patients, mostly due to severe pain. Radiotherapy is an established symptomatic treatment for painful bone metastases, however, when conventional techniques are used, the effectiveness is moderate. Stereotactic body rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercier, Carole, Dirix, Piet, Ost, Piet, Billiet, Charlotte, Joye, Ines, Vermeulen, Peter, Lievens, Yolande, Verellen, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727408/
https://www.ncbi.nlm.nih.gov/pubmed/31484505
http://dx.doi.org/10.1186/s12885-019-6097-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727408/
https://www.ncbi.nlm.nih.gov/pubmed/31484505
http://dx.doi.org/10.1186/s12885-019-6097-z

Ejemplares similares